ArticleCell reports2021

Integrin αvβ8 on T cells suppresses anti-tumor immunity in multiple models and is a promising target for tumor immunotherapy.

Eswari Dodagatta-Marri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.